Figure 1From: Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines In cell viability tests, treatment with sirolimus in concentrations of 1, 5, and 10 ng/mL did not affect cell viability in the THP-1 cells (a) and human monocytes (b). Back to article page